Tenax Therapeutics Inc (TENX) has risen Monday morning, with the stock adding 3.59% in pre-market trading to 5.19. TENX's short-term technical score of 23 indicates that the stock has traded less bullishly over the last month than 77% of stocks on the market. In the Biotechnology industry, which ranks 86 out of 146 industries, Tenax Therapeutics Inc ranks higher than 31% of stocks. Tenax Therapeutics Inc has fallen 49.65% over the past month, closing at $8.72 on February 5. During this period of time, the stock fell as low as $3.95 and as high as $21.46. TENX has an average analyst recommendation of Strong Buy. The company has an average price target of $32.50.
TENX has an Overall Score of 39. Find out what this means to you and get the rest of the rankings on TENX!